机构风向标 | 新光药业(300519)2025年三季度已披露前十大机构持股比例合计下跌2.47个百分点

Core Viewpoint - Xinguang Pharmaceutical (300519.SZ) reported its Q3 2025 results, highlighting a decrease in institutional investor holdings and a stable presence of public funds and foreign investments [1] Institutional Holdings - As of October 27, 2025, three institutional investors disclosed holdings in Xinguang Pharmaceutical, totaling 26.0257 million shares, which represents 16.27% of the company's total equity [1] - The institutional holding percentage decreased by 2.47 percentage points compared to the previous quarter [1] Public Fund Activity - In this reporting period, 52 public funds were disclosed, including notable funds such as Jinyuan Shun'an Yuanqi Flexible Allocation Mixed Fund and Huaxia CSI 500 Index Enhanced A [1] Social Security Fund - One new social security fund was disclosed, specifically the招商基金管理有限公司-社保基金1903组合 [1] Foreign Investment - One new foreign institution disclosed holdings, namely 中信证券资产管理(香港)有限公司-客户资金-人民币资金汇入, while BARCLAYS BANK PLC was not disclosed in this period [1]